Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.


Journal

Nature chemical biology
ISSN: 1552-4469
Titre abrégé: Nat Chem Biol
Pays: United States
ID NLM: 101231976

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 4 7 2019
medline: 4 7 2019
entrez: 4 7 2019
Statut: ppublish

Résumé

In the version of this article originally published, several lines of text in the last paragraph of the right column on page 1 of the PDF were transposed into the bottom paragraph of the left column. The affected text of the left column should read "The ATP-dependent activities of the BAF (SWI/SNF) chromatin remodeling complexes affect the positioning of nucleosomes on DNA and thereby many cellular processes related to chromatin structure, including transcription, DNA repair and decatenation of chromosomes during mitosis

Identifiants

pubmed: 31267096
doi: 10.1038/s41589-019-0329-z
pii: 10.1038/s41589-019-0329-z
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

846

Commentaires et corrections

Type : ErratumFor

Auteurs

William Farnaby (W)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Manfred Koegl (M)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Michael J Roy (MJ)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Claire Whitworth (C)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Emelyne Diers (E)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Nicole Trainor (N)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

David Zollman (D)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Steffen Steurer (S)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Jale Karolyi-Oezguer (J)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Carina Riedmueller (C)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Teresa Gmaschitz (T)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Johannes Wachter (J)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Christian Dank (C)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Michael Galant (M)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Bernadette Sharps (B)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Klaus Rumpel (K)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Elisabeth Traxler (E)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Thomas Gerstberger (T)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Renate Schnitzer (R)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Oliver Petermann (O)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Peter Greb (P)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Harald Weinstabl (H)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Gerd Bader (G)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Andreas Zoephel (A)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Alexander Weiss-Puxbaum (A)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Katharina Ehrenhöfer-Wölfer (K)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Simon Wöhrle (S)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Guido Boehmelt (G)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Joerg Rinnenthal (J)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Heribert Arnhof (H)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Nicola Wiechens (N)

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.

Meng-Ying Wu (MY)

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.

Tom Owen-Hughes (T)

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.

Peter Ettmayer (P)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Mark Pearson (M)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Darryl B McConnell (DB)

Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria. darryl.mcconnell@boehringer-ingelheim.com.

Alessio Ciulli (A)

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK. a.ciulli@dundee.ac.uk.

Classifications MeSH